Search results for "Triazine"

showing 10 items of 185 documents

In tube-solid phase microextraction-nano liquid chromatography: Application to the determination of intact and degraded polar triazines in waters and…

2017

Abstract In-tube solid-phase microextraction (IT-SPME) coupled to miniaturized liquid chromatography (LC) techniques are attractive mainly due to the column efficiency improvement, sensitivity enhancement and reduction of solvent consumption. In addition, the nanomaterials based sorbents can play a key role in the improvement of the extraction efficiency taking into account their interesting physical and chemical properties. Thus, in this work the performance of IT-SPME coupled to nano LC (NanoLC) has been compared with the performance of IT-SPME coupled to capillary LC (CapLC) with similar configurations for the determination of polar triazines including their degradation products. In both…

AnalyteCapillary actionStruviteSurface PropertiesAnalytical chemistry02 engineering and technologySolid-phase microextraction01 natural sciencesBiochemistrySensitivity and SpecificityAnalytical Chemistrychemistry.chemical_compoundLimit of DetectionPhase (matter)Chromatography High Pressure LiquidSolid Phase MicroextractionChromatographyElutionNanotubes CarbonTriazines010401 analytical chemistryOrganic ChemistryExtraction (chemistry)General Medicine021001 nanoscience & nanotechnology0104 chemical sciencesSolventchemistryStruvite0210 nano-technologyWater Pollutants ChemicalJournal of chromatography. A
researchProduct

Isoindolo[2,1-c]benzo[1,2,4]triazine: a New Ring System with Potential Antitumor Activity

2003

Antitumor activitychemistry.chemical_compoundchemistryStereochemistryRing (chemistry)Triazine
researchProduct

Azapropazone binding to human serum albumin

1980

Azapropazone, a new non-steroidal antiinflammatory drug, is strongly bound to human serum albumin. As revealed by Scatchard analysis, one high-affinity binding site with an association constant of about 1.2 x 10(6)M-1 and two low-affinity binding sites with association constants of about 0.05 x 10(6)M-1 were found. While the high-affinity binding site of azapropazone is clearly not identical with the diazepam or digitoxin binding sites of human serum albumin, contradictory evidence was found by optical measurements and displacement studies for the similarity of the azapropazone and the warfarin binding site of human serum albumin. At present, it is suggested that both drugs bind to differen…

ApazoneDigitoxinOptical measurementsEndogenyPlasma protein bindingIn Vitro TechniquesPharmacologyBinding CompetitivemedicineHumansBinding siteSerum AlbuminAzapropazonePharmacologyBinding SitesAntiinflammatory drugTriazinesChemistryCircular DichroismGeneral MedicineHuman serum albuminPhenylbutazoneBiochemistryDialysisProtein Bindingmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Facile synthesis of 5β-cholane-sym-triazine conjugates starting from metformin and bile acid methyl esters: Liquid and solid state NMR characterizati…

2009

Abstract Four bile acid-triazine conjugates: N2′,N2′-dimethyl-6′-(3α-hydroxy-5β-24-norcholyl)-1′,3′,5′-triazine-2′,4′-diamine (lithocholyl triazine, 4a), N2′,N2′-dimethyl-6′-(3α,7α-dihydroxy-5β-24-norcholyl)-1′,3′,5′-triazine-2′,4′-diamine (chenodeoxycholyl triazine, 4b), N2′,N2′-dimethyl-6′6′-(3α,12α-dihydroxy-5β-24-norcholyl)-1′,3′,5′-triazine-2′,4′-diamine (deoxycholyl triazine) (4c), and N2′,N2′-dimethyl-6′-(3α,7α,12α-trihydroxy-5β-24-norcholyl)-1′,3′,5′-triazine-2′,4′-diamine (cholyl triazine) (4d) have been prepared and characterized by liquid and solid state NMR. An improved synthetic method produced better yields and an easier purification procedure for 4d than reported in the liter…

Bile acidChemistrymedicine.drug_classOrganic ChemistryAnalytical ChemistryInorganic Chemistrychemistry.chemical_compoundCholaneSolid-state nuclear magnetic resonancePolymer chemistryX-ray crystallographymedicineOrganic chemistrySingle crystalSpectroscopyMonoclinic crystal systemConjugateTriazineJournal of Molecular Structure
researchProduct

Combination of supported liquid membrane and solid-phase extraction for sample pretreatment of triazine herbicides in juice prior to capillary electr…

2002

A possibility of a combination of supported liquid membrane (SLM) and solid-phase extraction (SPE) for the determination of atrazine at microgram level in different type of fruit juices is presented. In comparison to SPE extraction from juice samples, the application of SLM-SPE enrichment provides much cleaner extracts and the possibility of lowering the limit of detection as low as 30 microg/l. However, it was also shown that by appropriate manipulation of SLM extraction conditions mainly flow-rate of donor phase and volume ratio between donor and acceptor phase, the level of detection can be further decreased to 10 microg/l. The results suggest that the application of SLM extraction prior…

Biochemistryfruit juiceAnalytical ChemistryBeveragessupporter liquid membrane extractionchemistry.chemical_compoundCapillary electrophoresistriazinesSample preparationsolid-phase extractionSolid phase extractionAtrazineTriazineDetection limitChromatographyChemistryHerbicidesOrganic ChemistryElectrophoresis CapillaryMembranes ArtificialGeneral MedicinepesticidesMembraneCalibrationQuantitative analysis (chemistry)atrazineJournal of Chromatography A
researchProduct

A sustainable on-line CapLC method for quantifying antifouling agents like irgarol-1051 and diuron in water samples: Estimation of the carbon footpri…

2016

In this work, in-tube solid phase microextraction (in-tube SPME) coupled to capillary LC (CapLC) with diode array detection has been reported, for on-line extraction and enrichment of booster biocides (irgarol-1051 and diuron) included in Water Frame Directive 2013/39/UE (WFD). The analytical performance has been successfully demonstrated. Furthermore, in the present work, the environmental friendliness of the procedure has been quantified by means of the implementation of the carbon footprint calculation of the analytical procedure and the comparison with other methodologies previously reported. Under the optimum conditions, the method presents good linearity over the range assayed, 0.05-1…

BiocideEnvironmental Engineeringchemistry.chemical_element010501 environmental sciencesSolid-phase microextractionOnline Systems01 natural sciencesBiofoulingLimit of DetectionEnvironmental ChemistryWaste Management and DisposalSolid Phase MicroextractionCarbon Footprint0105 earth and related environmental sciencesDetection limitChromatographyFoulingHerbicidesTriazinesChemistry010401 analytical chemistryExtraction (chemistry)Pollution0104 chemical sciencesDiuronCarbon footprintCarbonWater Pollutants ChemicalChromatography LiquidDisinfectantsEnvironmental MonitoringScience of The Total Environment
researchProduct

The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models

2014

Background:Cetuximab is the only targeted agent approved for the treatment of head and neck squamous cell carcinomas (HNSCC), but low response rates and disease progression are frequently reported. As the phosphoinositide 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) pathways have an important role in the pathogenesis of HNSCC, we investigated their involvement in cetuximab resistance.Methods:Different human squamous cancer cell lines sensitive or resistant to cetuximab were tested for the dual PI3K/mTOR inhibitor PF-05212384 (PKI-587), alone and in combination, both in vitro and in vivo.Results:Treatment with PKI-587 enhances sensitivity to cetuximab in vitro, even in the co…

Cancer ResearchPathologyCetuximabApoptosisHNSCCHNSCCMiceAntineoplastic Combined Chemotherapy ProtocolsNeoplasmPhosphoinositide-3 Kinase InhibitorsMice Inbred BALB CCetuximabCaspase 3TriazinesTOR Serine-Threonine KinasesCetuximab resistanceErbB ReceptorsOncologyHead and Neck NeoplasmsMonoclonalCarcinoma Squamous Cellmedicine.drugmedicine.medical_specialtyMorpholinesPI3K-mTOR inhibitorsMice NudeAntineoplastic AgentsBiologyAntibodies Monoclonal HumanizedCell Line TumorAutophagymedicineCarcinomaAnimalsHumansneoplasmsPI3K/AKT/mTOR pathwayCell Proliferationcetuximab resistanceSquamous Cell Carcinoma of Head and Necktarget therapyCell growthAutophagyCancermedicine.diseaseXenograft Model Antitumor Assaysdigestive system diseasesDrug Resistance NeoplasmPI3K7mTOR inhibitorsCancer researchTranslational TherapeuticsBritish Journal of Cancer
researchProduct

Recent advances in the development of cyclin-dependent kinase 7 inhibitors.

2019

Abstract Cyclin dependent kinase 7 (CDK7) plays a double role as it activates several other cyclin dependent kinases and participates to the initiation of transcription. This kinase is overexpressed in various types of tumors. Relatively few selective CDK7 inhibitors have been up to now disclosed. Most of these inhibitors belong to two chemical families: pyrazolopyrimidines and pyrazolotriazines on one side and pyrimidines on another side. They also differ by their molecular mechanism of action. Some are acting as competitive inhibitors and some others are covalent inhibitors. With these tools, the understanding of the potential therapeutic interest of CDK7 inhibitors in cancer is rapidly g…

Cell SurvivalAntineoplastic Agents01 natural sciences03 medical and health sciencesDrug DevelopmentCyclin-dependent kinaseTranscription (biology)Cell Line TumorDrug DiscoverymedicineAnimalsHumansIC50Protein Kinase Inhibitors030304 developmental biologyPharmacology0303 health sciencesbiology010405 organic chemistryChemistryKinaseTriazinesOrganic ChemistryGeneral Medicinemedicine.diseaseCyclin-Dependent Kinases0104 chemical sciencesLeukemiaPyrimidinesbiology.proteinCancer researchMolecular mechanismCyclin-dependent kinase 7Cyclin-Dependent Kinase-Activating KinaseEuropean journal of medicinal chemistry
researchProduct

Synthesis, biological evaluation, and: In silico studies of novel chalcone: In pyrazoline-based 1,3,5-triazines as potential anticancer agents

2020

A novel series of triazin-chalcones (7,8)a-g and triazin-N-(3,5-dichlorophenyl)pyrazolines (9,10)a-g were synthesized and evaluated for their anticancer activity against nine different cancer strains. Triazine ketones 5 and 6 were synthesized from the cyanuric chloride 1 by using stepwise nucleophilic substitution of the chlorine atom. These ketones were subsequently subjected to a Claisen-Schmidt condensation reaction with aromatic aldehydes affording chalcones (7,8)a-g. Then, N-(3,5-dichlorophenyl)pyrazolines (9,10)a-g were obtained by cyclocondensation reactions of the respective chalcones (7,8)a-g with 3,5-dichlorophenylhydrazine. Among all the evaluated compounds, chalcones 7d,g and 8g…

ChalconeGeneral Chemical EngineeringCyanuric chloridePyrazolineTriazine derivatives01 natural sciencesClaisen Schmidt condensation03 medical and health scienceschemistry.chemical_compoundNucleophilic substitutionNucleophilic substitution030304 developmental biologyTriazinechemistry.chemical_classification0303 health sciences010405 organic chemistryLigandBiological evaluationGeneral ChemistryCondensation reactionCombinatorial chemistryCyclocondensation reaction0104 chemical sciencesEnzymechemistryAnticancer activitieThymidylate synthasePotential anticancer agent
researchProduct

Metal-free regioselective C–C bond cleavage in 1,3,5-triazine derivatives of β-diketones

2014

Metal-free regioselective activation of a carbon–carbon bond in 1,3,5-triazine derivatives of β-diketones is easily achieved, in the absence of a catalyst, with the assistance of intramolecular hydrogen bonding.

ChemistryHydrogen bondRegioselectivityGeneral ChemistryCatalysisCatalysischemistry.chemical_compound135-TriazineMetal freeIntramolecular forcePolymer chemistryMaterials ChemistryOrganic chemistryta116Bond cleavageNew J. Chem.
researchProduct